News / Yesterday

Sabinsa, Chemill Reach Licensing Agreement

Sabinsa Corp. and Chemill Inc. reached an agreement that resolves a previous lawsuit for infringement of Sabinsa’s U.S. Patent No. 6,653,327, covering compositions and uses of turmeric-derived tetrahydrocurcuminoids. The matter has been settled on undisclosed terms. Chemill will respect the patent as a due licensee.

News / September 22, 2016

Vitamin K2 Shown Again to Impact Cardiovascular Health

The results showed that high intake of menaquinones (vitamin K2) was associated with a reduced risk of CHD (coronary heart disease) (at least in hypertensive participants), while high intake of phylloquinone (vitamin K1) was not associated with any reduced risks.